Delivery Order SPE2DB22D3401-SPE2DB24FT1WB

Award Date 2/12/24
Potential Completion Date 3/5/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product GAMUNEX-C, a 40 gram/400 ml vial. The delivery order has a ceiling value of $14,427.24 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This contract is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product, with a potential value of $7,169.56 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of GAMUNEX-C 20 gram/200 ML vials, a specialty pharmaceutical product, with a potential value of $7,147.50 and a completion date of March 25, 2024. No set-aside designation was used for this award....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,530.00 contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, with a performance period through December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, a specialty pharmaceutical product, with a potential value of $16,397.85. The contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization that provides a wide range of pharmaceutical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 mL vials. The contract has a ceiling value of $3,036.70 and a period of performance through July 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of GAMUNEX-C 20 gram/200 ml vials, with a completion date of February 16, 2024 and a potential value of $14,295.00. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will provide these specialty pharmaceutical products to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 ml vials. The contract has a ceiling value of $6,073.40 and a period of performance through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global...
This is a $54,795.26 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, with a period of performance through March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,253.45, is for the supply of 4,567,958,190 units of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT1WB
    Delivery Order

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of GAMUNEX-C 20 gram/200 ML vials in support of military treatment programs and facilities. The potential value of this contract is $3,573.75, with a completion date of March 5, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has a broader indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical on behalf of the Department of Defense.

Generated 5/13/24, 9:25 AM